HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J Sieper Selected Research

Back Pain (Backache)

1/2011The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
7/2010[Spondyloarthritides].
7/2009Classification criteria for rheumatoid arthritis and ankylosing spondylitis.
6/2009New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
1/2009Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
12/2006Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
11/2006[Spondylarthritides].
9/2006Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
5/2005Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.
5/2004How to diagnose axial spondyloarthritis early.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


J Sieper Research Topics

Disease

72Ankylosing Spondylitis
10/2015 - 02/2000
23Necrosis
06/2011 - 04/2000
15Arthritis (Polyarthritis)
01/2011 - 01/2000
12Inflammation
01/2015 - 01/2000
11Rheumatoid Arthritis
06/2014 - 04/2000
11Back Pain (Backache)
01/2011 - 01/2000
8Psoriatic Arthritis
06/2014 - 02/2000
8Sacroiliitis
01/2011 - 01/2000
7Pain (Aches)
03/2008 - 06/2003
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2011 - 07/2001
6Reactive Arthritis (Reiter Disease)
06/2002 - 01/2000
3Osteoarthritis
01/2015 - 11/2000
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2011 - 05/2004
3Infection
01/2011 - 09/2000
3Anterior Uveitis
07/2010 - 05/2004
3Crohn Disease (Crohn's Disease)
11/2008 - 07/2001
3Body Weight (Weight, Body)
03/2008 - 04/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2014 - 01/2002
2Spondylarthritis (Spinal Arthritis)
06/2012 - 06/2003
2Rheumatic Diseases (Rheumatism)
01/2012 - 01/2012
2Ankylosis
07/2011 - 01/2000
2Uveitis
01/2011 - 01/2010
1Hypersensitivity (Allergy)
07/2011
1Chronic Disease (Chronic Diseases)
03/2010
1Iridocyclitis
01/2010
1Iritis
01/2010
1Ulcerative Colitis
05/2007
1Fatigue
12/2004
1Spinal Diseases (Disease, Spinal)
09/2004
1Asthma (Bronchial Asthma)
11/2002
1Atopic Dermatitis (Atopic Eczema)
11/2002
1Tuberculosis (Tuberculoses)
04/2002
1Connective Tissue Diseases (Connective Tissue Disease)
01/2002
1Mixed Connective Tissue Disease (MCTD)
01/2002
1Osteoporosis
07/2001
1Diarrhea
09/2000
1Spondylarthropathies
06/2000
1Myocarditis (Carditis)
06/2000
1Cardiomyopathies (Cardiomyopathy)
06/2000

Drug/Important Bio-Agent (IBA)

31Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 04/2000
24infliximab (Remicade)FDA Link
07/2011 - 06/2000
15TNFR-Fc fusion protein (etanercept)FDA Link
04/2011 - 07/2001
9Sulfasalazine (Azulfidine)FDA LinkGeneric
04/2011 - 01/2002
8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2012 - 01/2000
8C-Reactive ProteinIBA
06/2011 - 06/2003
8HLA-B27 Antigen (HLA B27 Antigen)IBA
06/2011 - 04/2000
7Antirheumatic Agents (DMARD)IBA
01/2012 - 11/2002
7O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
07/2010 - 01/2000
7CytokinesIBA
06/2006 - 04/2000
6AntigensIBA
01/2011 - 04/2000
6Interferon-gamma (Interferon, gamma)IBA
11/2008 - 04/2000
5Methotrexate (Mexate)FDA LinkGeneric
09/2010 - 04/2000
5Interleukin-10 (Interleukin 10)IBA
06/2006 - 04/2000
4Gadolinium DTPA (Magnevist)FDA Link
05/2005 - 02/2000
3CDP870FDA Link
10/2015 - 01/2014
3InterleukinsIBA
01/2015 - 06/2002
3Interleukin-4 (Interleukin 4)IBA
07/2003 - 04/2000
3AntibodiesIBA
04/2001 - 09/2000
2Interleukin-6 (Interleukin 6)IBA
01/2015 - 06/2006
2Carbon MonoxideIBA
01/2015 - 01/2002
2AutoantigensIBA
06/2014 - 07/2003
2Prednisolone (Predate)FDA LinkGeneric
01/2014 - 01/2002
2adalimumab (Humira)FDA Link
06/2009 - 05/2005
2Aligeron (AS 2)IBA
12/2006 - 08/2005
2SteroidsIBA
03/2006 - 09/2003
2Aggrecans (Aggrecan)IBA
05/2005 - 07/2003
2Interleukin-1 (Interleukin 1)IBA
02/2005 - 11/2000
2Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2004 - 09/2003
1AutoantibodiesIBA
06/2014
1Biological Markers (Surrogate Marker)IBA
06/2012
1N 30IBA
07/2011
1abatacept (BELATACEPT)FDA Link
06/2011
1rituximab (Mabthera)FDA Link
05/2010
1tebufenozide (Mimic)IBA
10/2009
1Virulence Factors (Pathogenicity Factors)IBA
11/2008
1Proteins (Proteins, Gene)IBA
11/2008
1Diclofenac (SR 38)FDA LinkGeneric
03/2008
1celecoxib (Celebrex)FDA Link
03/2008
1Transforming Growth Factor beta (TGF-beta)IBA
06/2006
1ParaffinIBA
06/2006
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2006
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2005
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2005
1leflunomide (Arava)FDA LinkGeneric
01/2005
1pamidronate (APD)FDA LinkGeneric
08/2003
1Monoclonal AntibodiesIBA
07/2003
1AS 35IBA
11/2002
1HLA-DRB1 antigen (HLA DRB1)IBA
06/2002
1Granulomatous allergic angiitisIBA
04/2002
1Antinuclear AntibodiesIBA
01/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2002
1SASIBA
01/2002
1PeptidesIBA
10/2001
1DiphosphonatesIBA
07/2001
1Vitamin DFDA LinkGeneric
07/2001
1RadiumIBA
04/2001
1Interleukin-1beta (Interleukin 1 beta)IBA
11/2000

Therapy/Procedure

2Biological Therapy
05/2005 - 09/2003
1Subcutaneous Injections
03/2007
1Withholding Treatment
02/2006